See more : Taiwan Taomee Co., Ltd. (6428.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of AlerisLife Inc. (ALR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AlerisLife Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- ACCELERATEBS INDIA LIMITED (ACCELERATE.BO) Income Statement Analysis – Financial Results
- Turquoise Hill Resources Ltd. (TRQ) Income Statement Analysis – Financial Results
- Scopus BioPharma Inc. (SCPS) Income Statement Analysis – Financial Results
- Sionix Corp. (SINX) Income Statement Analysis – Financial Results
- NRx Pharmaceuticals, Inc. (NRXPW) Income Statement Analysis – Financial Results
AlerisLife Inc. (ALR)
About AlerisLife Inc.
AlerisLife Inc. operates and manages senior living communities in the United States. It operates through two segments, Residential and Lifestyle Services. Its senior living communities comprise independent living communities, assisted living communities, memory care, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community. The company offers nursing and healthcare services; and outpatient rehabilitation clinics and fitness services. As of December 31, 2021, it owned and operated or managed, 141 senior living communities located in 28 states with 20,105 living units, including 10,423 independent living apartments, 9,636 assisted living suites, which includes 1,872 of Bridge to Rediscovery memory care units, and one continuing CCRC, with 106 living units, including 46 SNF. The company was formerly known as Five Star Senior Living Inc. and changed its name to AlerisLife Inc. in January 2022. AlerisLife Inc. was incorporated in 2001 and is headquartered in Newton, Massachusetts.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 934.59M | 1.16B | 1.42B | 1.39B | 1.40B | 1.38B | 1.37B | 1.33B | 1.30B | 1.35B | 1.28B | 1.24B | 1.19B | 1.10B | 972.92M | 827.34M | 757.53M | 628.01M | 576.22M | 522.51M | 229.24M |
| Cost of Revenue | 851.46M | 1.05B | 1.19B | 1.15B | 1.10B | 1.08B | 1.07B | 1.05B | 1.00B | 1.04B | 449.95M | 954.29M | 934.93M | 863.39M | 763.10M | 263.90M | 183.89M | 159.89M | 151.01M | 182.54M | 72.97M |
| Gross Profit | 83.13M | 115.79M | 229.87M | 245.05M | 291.74M | 297.77M | 292.11M | 282.99M | 294.80M | 309.16M | 831.82M | 286.44M | 257.63M | 240.81M | 209.82M | 563.44M | 573.64M | 468.11M | 425.20M | 339.97M | 156.27M |
| Gross Profit Ratio | 8.90% | 9.95% | 16.24% | 17.62% | 20.90% | 21.61% | 21.39% | 21.31% | 22.73% | 22.89% | 64.90% | 23.09% | 21.60% | 21.81% | 21.57% | 68.10% | 75.72% | 74.54% | 73.79% | 65.06% | 68.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 85.72M | 92.29M | 229.37M | 287.34M | 281.74M | 275.18M | 269.83M | 269.74M | 257.33M | 263.24M | 789.34M | 243.87M | 231.46M | 207.54M | 43.37M | 33.83M | 27.78M | 20.05M | 0.00 | 0.00 | 15.42M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 129.19M | 504.23M | 615.46M | 441.07M | 0.00 | 0.00 | 139.10M |
| SG&A | 85.72M | 92.29M | 229.37M | 287.34M | 281.74M | 275.18M | 269.83M | 269.74M | 257.33M | 263.24M | 789.34M | 243.87M | 231.46M | 207.54M | 172.56M | 538.06M | 643.24M | 461.12M | 428.02M | 345.16M | 154.51M |
| Other Expenses | 4.08M | 7.56M | 16.64M | 35.94M | 38.19M | 38.05M | 33.82M | 31.83M | 27.02M | 25.06M | 21.13M | 16.80M | 16.38M | 8.79M | 13.60M | 139.86M | 7.11M | 3.67M | 3.59M | 1.89M | 1.27M |
| Operating Expenses | 89.80M | 99.85M | 246.01M | 323.28M | 319.94M | 313.24M | 303.65M | 301.58M | 284.35M | 288.30M | 810.47M | 260.67M | 247.84M | 216.33M | 186.16M | 677.92M | 650.35M | 464.79M | 431.61M | 347.05M | 155.78M |
| Cost & Expenses | 941.26M | 1.15B | 1.43B | 1.47B | 1.42B | 1.39B | 1.38B | 1.35B | 1.29B | 1.33B | 1.26B | 1.21B | 1.18B | 1.08B | 949.26M | 941.82M | 834.24M | 624.68M | 582.62M | 529.59M | 228.75M |
| Interest Income | 358.00K | 757.00K | 1.36M | 818.00K | 765.00K | 984.00K | 982.00K | 867.00K | 781.00K | 881.00K | 1.30M | 1.82M | 2.99M | 5.92M | 6.15M | 6.81M | 1.54M | 1.67M | 229.00K | 297.00K | 43.00K |
| Interest Expense | 1.68M | 1.63M | 2.62M | 3.02M | 4.31M | 4.91M | 4.93M | 5.13M | 5.23M | 6.27M | 3.92M | 3.05M | 4.37M | 6.34M | 6.80M | 4.37M | 3.74M | 880.00K | 1.16M | 198.00K | 198.00K |
| Depreciation & Amortization | 11.87M | 11.75M | 16.64M | 35.94M | 38.19M | 38.05M | 33.67M | 33.47M | 28.11M | 25.06M | 21.13M | 16.80M | 16.38M | 14.72M | 13.60M | 9.95M | 7.11M | 3.67M | 3.59M | 1.89M | 1.32M |
| EBITDA | 5.57M | 27.70M | 1.87M | -34.88M | 17.06M | 23.50M | -3.82M | 9.58M | 32.91M | 61.92M | 38.69M | 44.79M | 61.27M | 17.95M | 45.13M | -102.35M | -73.30M | 7.96M | -3.19M | -11.09M | 1.85M |
| EBITDA Ratio | 0.60% | 2.38% | 0.13% | -2.51% | 1.22% | 1.71% | -0.28% | 0.72% | 2.54% | 4.58% | 3.02% | 3.61% | 5.14% | 1.63% | 4.64% | -12.37% | -9.68% | 1.27% | -0.55% | -2.12% | 0.81% |
| Operating Income | -6.31M | 15.94M | -14.77M | -71.56M | -23.05M | -15.97M | -37.02M | -19.18M | 10.26M | 20.86M | 21.35M | 25.77M | 9.80M | 18.55M | 23.66M | -114.48M | -76.71M | 3.32M | -6.40M | -10.03M | 484.00K |
| Operating Income Ratio | -0.67% | 1.37% | -1.04% | -5.15% | -1.65% | -1.16% | -2.71% | -1.44% | 0.79% | 1.54% | 1.67% | 2.08% | 0.82% | 1.68% | 2.43% | -13.84% | -10.13% | 0.53% | -1.11% | -1.92% | 0.21% |
| Total Other Income/Expenses | -23.21M | -22.87M | -5.74M | -2.79M | -2.99M | -3.82M | -3.09M | -3.87M | -5.23M | -1.79M | -3.63M | 441.00K | 31.66M | -16.74M | 3.84M | 2.44M | -4.53M | 786.00K | 0.00 | -348.00K | 43.00K |
| Income Before Tax | -29.51M | -6.93M | -20.51M | -74.35M | -26.05M | -19.79M | -40.12M | -23.05M | 5.03M | 19.07M | 17.72M | 26.21M | 41.45M | 1.82M | 27.51M | -112.04M | -81.25M | 4.11M | 0.00 | -10.38M | 527.00K |
| Income Before Tax Ratio | -3.16% | -0.60% | -1.45% | -5.35% | -1.87% | -1.44% | -2.94% | -1.74% | 0.39% | 1.41% | 1.38% | 2.11% | 3.48% | 0.16% | 2.83% | -13.54% | -10.73% | 0.65% | 0.00% | -1.99% | 0.23% |
| Income Tax Expense | 234.00K | 663.00K | 56.00K | 247.00K | -4.54M | 2.35M | 662.00K | 56.39M | 1.92M | 5.64M | -50.55M | 1.45M | 2.20M | 1.39M | 1.41M | 4.63M | 2.91M | 120.00K | 1.16M | -150.00K | 2.80M |
| Net Income | -29.75M | -7.59M | -20.57M | -74.08M | -20.90M | -21.81M | -43.08M | -85.41M | -2.34M | 24.95M | 64.20M | 23.49M | 38.33M | -4.50M | 23.33M | -116.67M | -84.16M | 3.29M | -7.94M | -13.17M | 527.00K |
| Net Income Ratio | -3.18% | -0.65% | -1.45% | -5.33% | -1.50% | -1.58% | -3.16% | -6.43% | -0.18% | 1.85% | 5.01% | 1.89% | 3.21% | -0.41% | 2.40% | -14.10% | -11.11% | 0.52% | -1.38% | -2.52% | 0.23% |
| EPS | -0.94 | -0.24 | -4.11 | -14.91 | -4.25 | -4.47 | -8.90 | -17.78 | -0.48 | 5.20 | 15.23 | 6.57 | 11.42 | -1.41 | 7.36 | -40.78 | -56.56 | 3.78 | -9.36 | -17.44 | 1.20 |
| EPS Diluted | -0.94 | -0.24 | -4.11 | -14.91 | -4.25 | -4.47 | -8.90 | -17.78 | -0.48 | 5.20 | 14.26 | 5.99 | 9.89 | -1.41 | 5.63 | -40.78 | -56.56 | 3.78 | -9.36 | -17.44 | 1.20 |
| Weighted Avg Shares Out | 31.59M | 31.47M | 5.01M | 4.97M | 4.92M | 4.88M | 4.84M | 4.80M | 4.83M | 4.80M | 4.22M | 3.57M | 3.36M | 3.19M | 3.17M | 2.86M | 1.49M | 871.60K | 848.20K | 755.60K | 437.40K |
| Weighted Avg Shares Out (Dil) | 31.59M | 31.47M | 5.01M | 4.97M | 4.92M | 4.88M | 4.84M | 4.80M | 4.93M | 4.80M | 4.50M | 3.92M | 3.88M | 3.19M | 4.14M | 2.86M | 1.49M | 871.60K | 848.20K | 755.60K | 437.40K |
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alere Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Alere Inc. (“Alere” or the “Company”) (NYSE: ALR) concerning possible violations of federal securities laws between February 29, 2012 and November 4,...
SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Alere Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Alere Inc. (“Alere” or the “Company”) (NYSE: ALR). Investors who purchased or otherwise acquired Alere shares between February 29, 2012...
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Alere Inc. - ALR
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers Alere Inc. securities (NYSE:ALR) from February 29, 2012 through November 4, 2016, both dates inclusive (the...
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Alere Inc. and Advises Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Alere Inc. (“Alere” or the “Company”) (NYSE: ALR) concerning possible violations of federal securities laws. To get more information about this investigation, please contact...
SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Alere Inc. and Advises Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Alere Inc. (“Alere” or the “Company”) (NYSE: ALR) concerning possible violations of federal securities laws. If you purchased or otherwise acquired Alere shares and...
Pharos Capital Acquires TechLab, Leading Developer of Gastrointestinal Disease Diagnostics
DALLAS & NASHVILLE, Tenn.--(BUSINESS WIRE)--Pharos Capital Group, LLC (“Pharos”), a private equity firm based in Dallas and Nashville, announced it has acquired a controlling position in TechLab, Inc. (“TechLab” or “the Company”), a developer and manufacturer of rapid, non-invasive diagnostic...
GPM Reminds Investors of the June 20 Deadline in the Class Action Lawsuit Against Alere Inc.
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the June 20, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the “Class”) of investors who purchased Alere Inc....
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. and Advises Investors with Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC announces a class action lawsuit has been filed against Alere Inc. (“Alere” or the “Company”) (NYSE: ALR) concerning possible violations of federal securities laws between May 9, 2013 and April 20, 2016. Investors who purchased...
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. and Advises Investors With Losses to Contact the Firm
LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC announces a class action lawsuit has been filed against Alere Inc. (“Alere” or the “Company”) (NYSE: ALR) concerning possible violations of federal securities laws between May 9, 2013 and April 20, 2016. Investors who purchased...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Alere Inc. of Commencement of Class Action Lawsuit and a Lead Plaintiff Deadline of June 20, 2016
NEW YORK--(BUSINESS WIRE)--The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Alere Inc. (“Alere” or “the Company”) (NYSE: ALR) between May 9, 2013 and April 20,...
Source: https://incomestatements.info
Category: Stock Reports